Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period

MLA

Alper Şener, et al. “Preadmission Usage of Metformin and Mortality in COVID-19 Patients Including the Post-Discharge Period.” Irish Journal of Medical Science (1971 -), vol. 191, Oct. 2021, pp. 569–75. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cb7a98fad58e31c47843cdcf00fcbac&authtype=sso&custid=ns315887.

APA

Alper Şener, Erdal Mert, Emre Sedar Saygili, Arzu Mirci, & Ersen Karakilic. (2021). Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period. Irish Journal of Medical Science (1971 -), 191, 569–575.

Chicago

Alper Şener, Erdal Mert, Emre Sedar Saygili, Arzu Mirci, and Ersen Karakilic. 2021. “Preadmission Usage of Metformin and Mortality in COVID-19 Patients Including the Post-Discharge Period.” Irish Journal of Medical Science (1971 -) 191 (October): 569–75. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1cb7a98fad58e31c47843cdcf00fcbac&authtype=sso&custid=ns315887.